Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06269133
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-13
First Post:
2024-02-13
Brief Title:
Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line 1L Treatment of Advanced Non-Small Cell Lung Cancer NSCLC in Adult United States US Patients
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-21
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-23
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-13
First Submit QC Date:
February 13 2024
Study First Post Date:
2024-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-06
Last Update Post Date:
2024-03-13
Last Update Post Date Type:
ACTUAL